Gayer Fabian A, Klaus Lucas, Reichardt Sybille D, Fichtner Alexander, Reichardt Holger M
Institute for Cellular and Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
Clinic of Urology, University Medical Center Göttingen, Göttingen, Germany.
Andrology. 2025 Jul;13(5):1213-1222. doi: 10.1111/andr.13717. Epub 2024 Jul 29.
Testicular germ cell tumor (TGCT) is the most common type of tumor in young men. Type II germ cell tumors including postpubertal-type teratomas are derived from the germ cell neoplasia in situ (GCNIS), whereas prepubertal-type teratomas arise independently of the GCNIS. The consomic mouse strain 129.MOLF-Chr19 (M19) is a suitable murine model of such tumors, but its characterization remains incomplete.
Here, we interrogated the suitability of testicular tumors in M19 mice as a model of human TGCT by analyzing their histological features and gene expression signature.
Testes collected from M19 mice of different ages were categorized by macroscopic appearance based on size and the degree of suspected tumorigenesis. Histological sections from selected tumors were stained with Hematoxylin and Eosin, and expression of genes associated with tumorigenesis was determined in frozen tissue samples from a large range of tumors of different subclasses using RT-qPCR and Fluidigm Dynamic Arrays.
Macroscopically, testicular specimens appeared very heterogeneous concerning size and signs indicating the presence of a tumor. Histological analysis confirmed the development of teratomas with areas of cells corresponding to all three germ cell layers. Gene expression analyses indicated upregulation of markers related to proliferation, vascular invasive potential and pluripotency, and revealed a strong correlation of gene expression with tumor size and a significant intercorrelation of individual genes.
TGCT in M19 mice is reminiscent of human testicular teratomas presenting with areas of cells derived from all germ layers and showing a typical gene signature. We thus confirm that these mice can serve as a suitable murine model of pure teratomas for preclinical research.
睾丸生殖细胞肿瘤(TGCT)是年轻男性中最常见的肿瘤类型。包括青春期后型畸胎瘤在内的II型生殖细胞肿瘤源自原位生殖细胞肿瘤(GCNIS),而青春期前型畸胎瘤独立于GCNIS发生。染色体代换小鼠品系129.MOLF-Chr19(M19)是此类肿瘤的合适小鼠模型,但其特征仍不完整。
在此,我们通过分析M19小鼠睾丸肿瘤的组织学特征和基因表达特征,探讨其作为人类TGCT模型的适用性。
根据大小和疑似肿瘤发生程度,对不同年龄M19小鼠的睾丸进行宏观外观分类。从选定肿瘤中获取的组织学切片用苏木精和伊红染色,并使用RT-qPCR和Fluidigm动态阵列在来自不同亚类的大量肿瘤的冷冻组织样本中测定与肿瘤发生相关基因的表达。
宏观上,睾丸标本在大小和表明存在肿瘤的迹象方面表现出很大的异质性。组织学分析证实了畸胎瘤的发生,其细胞区域对应于所有三个胚层。基因表达分析表明与增殖、血管侵袭潜能和多能性相关的标志物上调,并揭示了基因表达与肿瘤大小之间的强相关性以及各个基因之间的显著相互相关性。
M19小鼠中的TGCT让人联想到人类睾丸畸胎瘤,其具有来自所有胚层的细胞区域并显示出典型的基因特征。因此,我们证实这些小鼠可作为纯畸胎瘤的合适小鼠模型用于临床前研究。